Cheryl-Anne S.


Beaconsfield, QC – As a patient who was diagnosed with Chronic Myelogenous Leukemia (CML) almost 13 years ago, my interest in digital health and access to my specialist through email has helped me tremendously in being fully engaged as a patient in my own health management. Results of the specialized molecular tests can be emailed to me directly so that I can track my progress on an ongoing basis. It also allows me to inform my health care team of any problems that may affect treatment adherence, such as side effects and quality of life issues, so that they can be managed more effectively.  Additionally, as President and CEO of The Chronic Myelogenous Leukemia Society of Canada we have engaged other talented patients with CML to take leadership in their disease management by designing APP’s and programs that help CML patients to better manage and track their progress while staying adherent to the long term therapy/treatment of CML. I firmly believe that continued investment in digital health will certainly help us to maximize savings to the healthcare system by reducing the number of administrative functions that are involved with providing patients with updates of their health records and other requests that can be digitalized for easy access by the patients when it is most convenient to them.